Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1724-6059
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease ; day:23 ; month:11 ; year:2022 ; pages:1-33
Journal of nephrology ; (23.11.2022), 1-33
- Urheber
-
Folkerts, Kerstin
Millier, Aurelie
Smela, Beata
Olewinska, Elzbieta
Schmedt, Niklas
Mernagh, Paul
Kovesdy, Csaba P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40620-022-01492-w
- URN
-
urn:nbn:de:101:1-2023020509123347253654
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Folkerts, Kerstin
- Millier, Aurelie
- Smela, Beata
- Olewinska, Elzbieta
- Schmedt, Niklas
- Mernagh, Paul
- Kovesdy, Csaba P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Effects of a novel non-steroidal mineralocorticoid receptor antagonist on cardiac hypertrophy
Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Nephrocalcinosis, calcium antagonists, and kidney
Calcium antagonists and the kidney
A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Effects of a novel non-steroidal mineralocorticoid receptor antagonist on cardiac hypertrophy
Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Nephrocalcinosis, calcium antagonists, and kidney
Calcium antagonists and the kidney
A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Effects of a novel non-steroidal mineralocorticoid receptor antagonist on cardiac hypertrophy
Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Nephrocalcinosis, calcium antagonists, and kidney
Calcium antagonists and the kidney